Correlation Between Phoenix Biotech and Fat Projects

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Phoenix Biotech and Fat Projects at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Phoenix Biotech and Fat Projects into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Phoenix Biotech Acquisition and Fat Projects Acquisition, you can compare the effects of market volatilities on Phoenix Biotech and Fat Projects and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Phoenix Biotech with a short position of Fat Projects. Check out your portfolio center. Please also check ongoing floating volatility patterns of Phoenix Biotech and Fat Projects.

Diversification Opportunities for Phoenix Biotech and Fat Projects

-0.18
  Correlation Coefficient

Good diversification

The 3 months correlation between Phoenix and Fat is -0.18. Overlapping area represents the amount of risk that can be diversified away by holding Phoenix Biotech Acquisition and Fat Projects Acquisition in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fat Projects Acquisition and Phoenix Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Phoenix Biotech Acquisition are associated (or correlated) with Fat Projects. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fat Projects Acquisition has no effect on the direction of Phoenix Biotech i.e., Phoenix Biotech and Fat Projects go up and down completely randomly.

Pair Corralation between Phoenix Biotech and Fat Projects

Assuming the 90 days horizon Phoenix Biotech Acquisition is expected to generate 1.99 times more return on investment than Fat Projects. However, Phoenix Biotech is 1.99 times more volatile than Fat Projects Acquisition. It trades about 0.16 of its potential returns per unit of risk. Fat Projects Acquisition is currently generating about 0.1 per unit of risk. If you would invest  4.50  in Phoenix Biotech Acquisition on August 30, 2024 and sell it today you would earn a total of  1.61  from holding Phoenix Biotech Acquisition or generate 35.78% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy49.22%
ValuesDaily Returns

Phoenix Biotech Acquisition  vs.  Fat Projects Acquisition

 Performance 
       Timeline  
Phoenix Biotech Acqu 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Phoenix Biotech Acquisition has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Phoenix Biotech is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
Fat Projects Acquisition 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Fat Projects Acquisition has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Fat Projects is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Phoenix Biotech and Fat Projects Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Phoenix Biotech and Fat Projects

The main advantage of trading using opposite Phoenix Biotech and Fat Projects positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Phoenix Biotech position performs unexpectedly, Fat Projects can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fat Projects will offset losses from the drop in Fat Projects' long position.
The idea behind Phoenix Biotech Acquisition and Fat Projects Acquisition pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Other Complementary Tools

Money Managers
Screen money managers from public funds and ETFs managed around the world
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world